Abstract

Hemodialysis therapy was first performed in Japan at United States military base hospitals during the Korean War (1950–1953) to treat injured American soldiers with crush syndrome transferred from the combat zone. Encouraged by such experiences, several university hospitals started to offer acute hemodialysis treatment in 1955 and chronic hemodialysis treatment in the early 1960s. The health insurance program started to cover chronic hemodialysis treatment in 1967. Initially, the costs were not fully covered by the program: a 30% to even 50% copayment was required for patients who were not beneficiaries of the public insurance plan. In 1972, the national government started a program that also covered copayment on the basis of the Basic Act for Persons with Disabilities as a result of lobbying activities by patient groups and academic societies. Since then, hemodialysis treatment has become almost free of charge, except for high-income patients (up to 20,000 Japanese Yen [JPY] or approximately United States $200 per month). Typically, the total monthly cost for a patient on maintenance dialysis is approximately 320,000 JPY or approximately United States $3000, excluding any additional fees or medications. The cost consists of the medical management fee, including routine laboratory tests (22,500 JPY per month), and technical fees (21,400 JPY × approximately 14/mo). The reimbursement system is updated every 2 years. In April 2006, the costs for erythropoiesis-stimulating agents were bundled with the technical fees of hemodialysis and with anticoagulant and normal saline for rinsing. Roxadustat has recently been approved and bundled. According to the recent annual report of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) (1), a total of 334,505 patients (2640.0 per million people in the general population) are receiving dialysis treatment in Japan as of 2017. In 40,959 incident patients (323 per million people in the general population), the average …

Highlights

  • Hemodialysis therapy was first performed in Japan at United States military base hospitals during the Korean War (1950–1953) to treat injured American soldiers with crush syndrome transferred from the combat zone

  • Twenty-three thousand clinical engineers (CEs) had jobs in dialysis facilities as of 2016 (2). They support the maintenance and performance of dialysis machines but are highly responsible for maintaining dialysate quality, including water purity. This is quite important because dialysis fluid is delivered from a central system in most facilities in Japan, except for a few patients who need special prescriptions

  • Basic cost to be reimbursed for a single hemodialysis session Professionals managing patients

Read more

Summary

Introduction

Hemodialysis therapy was first performed in Japan at United States military base hospitals during the Korean War (1950–1953) to treat injured American soldiers with crush syndrome transferred from the combat zone. Twenty-three thousand CEs had jobs in dialysis facilities as of 2016 (2) They support the maintenance and performance of dialysis machines but are highly responsible for maintaining dialysate quality, including water purity. This is quite important because dialysis fluid is delivered from a central system in most facilities in Japan, except for a few patients who need special prescriptions.

Diabetes as the primary diagnosis of ESKD
Types of vascular access
Findings
Practice Pattern and Prognosis of Japanese Patients on Dialysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call